Amgen (AMGN) Price to Earnings (2009 - 2026)

Amgen has reported Price to Earnings for 18 years, with the latest figure at 82.43 in Q2 2026.

• On a quarterly basis, Price to Earnings fell 21.47% year-over-year to 82.43 in Q2 2026; TTM through Jun 2026 was 22.39, a 1.39% decrease from a year earlier, with the FY2025 full-year figure at 22.87, down 33.16% from the prior year.
• Price to Earnings was 82.43 for Q2 2026 at Amgen, down from 104.39 in the prior quarter.
• The five-year high for Price to Earnings was 225.0 in Q2 2024, with the low at 1349.64 in Q1 2024.
• Average Price to Earnings over 5 years is 26.27, with a median of 87.15 recorded in 2022.
• The largest YoY upside for Price to Earnings was 161.26% in 2024 against a maximum downside of 3068.5% in 2024.
• Over 5 years, Price to Earnings stood at 86.79 in 2022, then soared by 131.66% to 201.05 in 2023, then grew by 11.01% to 223.19 in 2024, then slumped by 40.72% to 132.3 in 2025, then tumbled by 37.7% to 82.43 in 2026.
• The last three Price to Earnings figures came in at 82.43 (Q2 2026), 104.39 (Q1 2026), and 132.3 (Q4 2025), per Business Quant data.